Trade Summary

5 days ago, Leonard Braden Michael, serving as 10% owner at Aclaris Therapeutics, Inc. (ACRS), sold 300,000 shares at $4.53 per share, for a total transaction value of $1,359,000.00. Following this transaction, Leonard Braden Michael now holds 13,950,000 shares of ACRS.

This sale represents a 2.00% decrease in Leonard Braden Michael's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Thursday, April 23, 2026 and publicly disclosed via SEC Form 4 filing on Monday, April 27, 2026, 4 days after the trade was made.

Aclaris Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.